Praj Industries Partnership
Praj signed a Bio-IBA Development & Commercialization Agreement with Gevo Inc. for exclusive Indian deployment. The deal targets diesel blending and includes India's first Bio-IBA demonstration plant.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements
Praj signed a Bio-IBA Development & Commercialization Agreement with Gevo Inc. for exclusive Indian deployment. The deal targets diesel blending and includes India's first Bio-IBA demonstration plant.
Endurance reports strong Q1 FY27 growth despite global macro volatility, with consolidated income rising 29.6% and EBITDA 18.7%. Profits grew but margins remain compressed by rising commodity prices.
Praj reported Q1-FY27 consolidated revenue of INR 7,158 Mn, up 11.8% YoY, driven by Bioenergy. Consolidated PAT grew significantly YoY to INR 116 Mn.
Praj Industries Ltd reported revenue from operations of ₹715.8 Cr (+11.8% YoY) and net profit of ₹11.6 Cr (+118.9% YoY) for Q1 FY27.
Praj reports FY26 revenue of INR 31,679 Mn with 4.79% EBITDA margin. The company is transitioning from Bioenergy dominance toward modularized Engineering and HiPurity solutions.
Praj Q4 FY26 earnings transcript. Management discussed external headwinds impacting 1G ethanol performance while highlighting strategic pivots to SAF, GenX, and CBG segments.
Praj reported a challenging FY26 with consolidated revenue down 1.9% and PAT down 89.1% YoY, impacted by ethanol overcapacity and project slowdowns.
Praj Industries Ltd reported revenue from operations of ₹844.6 Cr (-1.8% YoY) and net profit of ₹11.6 Cr (-70.9% YoY) for Q4 FY26.